{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:34:02Z","timestamp":1789043642743,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In Japan, oral third-generation cephalosporins with broad-spectrum activity are commonly prescribed in the practices of dentistry and oral surgery. However, there are few reports on the appropriate use of antibiotics in the field of oral surgery. This study aimed to evaluate the appropriateness of antibiotic use before and after an educational intervention in the Department of Oral and Maxillofacial Surgery, Kobe University Hospital.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The use of oral antibiotics was investigated among inpatients and outpatients before and after an educational intervention conducted by the antimicrobial stewardship team. Additionally, the frequency of surgical site infection after the surgical removal of an impacted third mandibular molar under general anesthesia and the prevalence of adverse effects of the prescribed antibiotics were comparatively evaluated between 2013 and 2018.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After the educational intervention, a remarkable reduction was noted in the prescription of oral third-generation cephalosporins, but increased use of penicillins was noted among outpatients. There was reduced use of macrolides and quinolones in outpatients. Although a similar trend was seen for inpatients, the use of quinolones increased in this population. Despite the change in the pattern of antibiotic prescription, inpatients who underwent mandibular third molar extraction between 2013 and 2018 did not show a significant increase in the prevalence of surgical site infections (6.2% vs. 1.8%, <jats:italic>p<\/jats:italic>\u2009=\u2009.336) and adverse effects of drugs (2.1% vs. 0%, <jats:italic>p<\/jats:italic>\u2009=\u2009.466).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study suggests that the judicious use of oral antibiotics is possible through conscious and habitual practice of appropriate antibiotic use. However, further investigation is required to develop measures for appropriate use of oral antibiotics.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12903-020-01367-1","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T19:03:18Z","timestamp":1610046198000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Effect of educational intervention on the appropriate use of oral antimicrobials in oral and maxillofacial surgery: a retrospective secondary data analysis"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4289-1852","authenticated-orcid":false,"given":"Junya","family":"Kusumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Uda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shungo","family":"Furudoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Yoshii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Miyara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"1367_CR1","unstructured":"CDC (Centers for Disease Control and Prevention). Antibiotic resistance threats in the United States, 2013. Centers for Disease Control and Prevention, US Department of Health and Human Services. 2013. https:\/\/www.cdc.gov\/drugresistance\/threat-report-2013\/pdf\/ar-threats-2013-508.pdf."},{"key":"1367_CR2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.15585\/mmwr.mm6509e1","volume":"65","author":"LM Weiner","year":"2016","unstructured":"Weiner LM, Fridkin SK, Apontes-Torres Z, Avery L, Coffin N, Dudeck MA, et al. Vital signs: preventing antibiotic-resistant infections in hospitals-United States, 2014. Morb Mortal Wkly Rep. 2016;65:235\u201341.","journal-title":"Morb Mortal Wkly Rep"},{"key":"1367_CR3","unstructured":"O'neill J. Antimicrobial resistance. Tackling a crisis for the health and wealth of nations. 2014. http:\/\/www.jpiamr.eu\/wp-content\/uploads\/2014\/12\/AMR-Review-Paper-Tackling-a-crisis-for-the-health-and-wealth-of-nations_1-2.pdf."},{"key":"1367_CR4","unstructured":"World Health Organization. Global action plan on antimicrobial resistance. 2015."},{"key":"1367_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jgar.2016.07.002","volume":"7","author":"Y Muraki","year":"2016","unstructured":"Muraki Y, Yagi T, Tsuji Y, Nishimura N, Tanabe M, Niwa T, et al. Japanese antimicrobial consumption surveillance: first report on oral and parenteral antimicrobial consumption in Japan (2009\u20132013). J Glob Antimicrob Resist. 2016;7:19\u201323.","journal-title":"J Glob Antimicrob Resist"},{"key":"1367_CR6","unstructured":"The Government of Japan. National action plan on antimicrobial resistance (AMR) 2016\u20132020. 2016."},{"key":"1367_CR7","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.ajic.2016.05.008","volume":"44","author":"H Umematsu","year":"2016","unstructured":"Umematsu H, Yamashita K, Kunisawa S, Fushimi K, Imanaka Y. The economic burden of methicillin-resistant Staphylococcus aureus in community-onset pneumonia inpatients. Am J Infect Control. 2016;44:1628\u201333. https:\/\/doi.org\/10.1016\/j.ajic.2016.05.008.","journal-title":"Am J Infect Control"},{"key":"1367_CR8","unstructured":"ECDC E. Antimicrobial resistance surveillance in Europe 2012. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) Stockholm. 2013.http:\/\/ecdc.europa.eu\/sites\/portal\/files\/media\/en\/publications\/Publications\/antimicrobial-consumption-europe-esac-net-2012.pdf."},{"key":"1367_CR9","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1086\/512810","volume":"44","author":"H Goossens","year":"2007","unstructured":"Goossens H, Ferech M, Goenen S, Stephens P, European Surveillance of Antimicrobial Consumption Project Group. Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin Infect Dis. 2007;44:1091\u20135.","journal-title":"Clin Infect Dis"},{"key":"1367_CR10","doi-asserted-by":"publisher","DOI":"10.1201\/b13787","volume-title":"Kucers\u2019 the use of antibiotics sixth edition: a clinical review of antibacterial, antifungal and antiviral drugs","author":"ML Grayson","year":"2010","unstructured":"Grayson ML, Crowe SM, McCarthy JS, Mills J, Mouton JW, Norrby SR, et al. Kucers\u2019 the use of antibiotics sixth edition: a clinical review of antibacterial, antifungal and antiviral drugs. Boca Raton: CRC Press; 2010."},{"key":"1367_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1089\/107662903764736337","volume":"9","author":"K Hasegawa","year":"2003","unstructured":"Hasegawa K, Yamamoto Y, Chiba N, Kobayashi R, Nagai K, Jacobs MR, et al. Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States. Microb Drug Resist. 2003;9:39\u201346.","journal-title":"Microb Drug Resist"},{"key":"1367_CR12","doi-asserted-by":"publisher","first-page":"e00851","DOI":"10.1128\/AAC.00851-18","volume":"62","author":"H Honda","year":"2018","unstructured":"Honda H, Sato T, Shinagawa M, Fukushima Y, Nakajima C, Suzuki Y, et al. Multiclonal expansion and high prevalence of \u03b2-lactamase-negative Haemophilus influenzae with high-level ampicillin resistance in Japan and susceptibility to quinolones. Antimicrob Agents Chemother. 2018;62:e00851-e918.","journal-title":"Antimicrob Agents Chemother"},{"key":"1367_CR13","unstructured":"Holyfield G, Karki A. Review of prescribing by dentists in Wales. Cardiff \u00e9 National Public Health Service for Wales. 2009."},{"key":"1367_CR14","unstructured":"Health and Social Care Information Centre. Prescribing by Dentists, England 2014: Annex 2, raw data. 2015. https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/prescribing-by-dentists\/prescribing-by-dentists-england-2014."},{"key":"1367_CR15","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1177\/154411130401500604","volume":"15","author":"PN Nair","year":"2004","unstructured":"Nair PN. Pathogenesis of apical periodontitis and the causes of endodontics failures. Crit Rev Oral Biol Med. 2004;15:348\u201381.","journal-title":"Crit Rev Oral Biol Med"},{"key":"1367_CR16","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.jcms.2008.07.001","volume":"36","author":"PH Warnke","year":"2008","unstructured":"Warnke PH, Becker ST, Springer IN, Haerle F, Ullmann U, Russo PA, et al. Penicillin compared with other advanced broad spectrum antibiotics regarding antibacterial activity against oral pathogens isolated from odontogenic abscess. J Craniomaxillofac Surg. 2008;36:462\u20137.","journal-title":"J Craniomaxillofac Surg"},{"key":"1367_CR17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4103\/0976-237X.137921","volume":"5","author":"R Bahl","year":"2014","unstructured":"Bahl R, Sandhu S, Singh K, Sahai N, Gupta M. Odontogenic infections: microbiology and management. Contemp Clin Dent. 2014;5:307\u201311.","journal-title":"Contemp Clin Dent"},{"key":"1367_CR18","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/jac\/dkh137","volume":"53","author":"LC Sweeney","year":"2004","unstructured":"Sweeney LC, Dave J, Chambers PA, Heritage J. Antibiotic resistance in general dental practice\u2014a cause for concern? J Antimicrob Chemother. 2004;53:567\u201376.","journal-title":"J Antimicrob Chemother"},{"issue":"2606","key":"1367_CR19","first-page":"e1","volume":"75","author":"JR Martins","year":"2017","unstructured":"Martins JR, Chagas OL Jr, Velasques BD, Bobrowski AN, Correa MB, Torriani MA. The use of antibiotics in odontogenic infections: What is the best choice? A systematic review. J Oral Maxillofac Surg. 2017;75(2606):e1-11.","journal-title":"J Oral Maxillofac Surg"},{"key":"1367_CR20","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.14219\/jada.archive.2000.0090","volume":"131","author":"JB Epstein","year":"2000","unstructured":"Epstein JB, Chong S, Le ND. A survey of antibiotic use in dentistry. J Am Dent Assoc. 2000;131:1600\u20139.","journal-title":"J Am Dent Assoc"},{"key":"1367_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2147\/TCRM.S9736","volume":"6","author":"NS Dar-Odeh","year":"2010","unstructured":"Dar-Odeh NS, Abu-Hammad OA, Al-Omiri MK, Khraisat AS, Shehabi AA. Antibiotic prescribing practices by dentists: a review. Ther Clin Risk Manag. 2010;6:301\u20136.","journal-title":"Ther Clin Risk Manag"},{"key":"1367_CR22","unstructured":"Ministry of Health, Labour and Welfare. Antibiotic usage surveillance in the dental field based on information database (NDB) such as receipt information and specific medical examinations. NDB Open Data [In Japanese]. http:\/\/amrcrc.ncgm.go.jp\/surveillance\/010\/20181128172333.html, http:\/\/amrcrc.ncgm.go.jp\/surveillance\/010\/20190315dentist_NDB_fig_JAPAN.pdf."},{"key":"1367_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12887-017-0835-7","volume":"17","author":"M Ito","year":"2017","unstructured":"Ito M, Fukuda M, Suzuki Y, Wakamoto H, Ishii E. Carnitine-related hypoglycemia caused by 3 days of pivalate antibiotic therapy in a patient with severe muscular dystrophy: a case report. BMC Pediatr. 2017;17:73.","journal-title":"BMC Pediatr"},{"key":"1367_CR24","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s15010-019-01362-x","volume":"47","author":"A Uda","year":"2019","unstructured":"Uda A, Kimura T, Nishimura S, Ebisawa K, Ohji G, Kusuki M, et al. Efficacy of educational intervention on reducing the inappropriate use of oral third-generation cephalosporins. Infection. 2019;47:1037\u201345.","journal-title":"Infection"},{"key":"1367_CR25","unstructured":"Practical guidelines for the appropriate use of antibacterial agents to prevent postoperative infection [in Japanese]. Japanese association for infectious disease\/Japanese society of chemotherapy; JAID\/JSC committee for developing treatment guide and guidelines for clinical management of infectious disease 2016. http:\/\/www.chemotherapy.or.jp\/guideline\/jyutsugo_shiyou_jissen.pdf."},{"key":"1367_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1086\/501620","volume":"20","author":"AJ Mangram","year":"1999","unstructured":"Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR, Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Infect Cont Hosp Epidemiol. 1999;20:247\u201380.","journal-title":"Infect Cont Hosp Epidemiol."},{"key":"1367_CR27","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.adaj.2019.05.028","volume":"150","author":"MJ Dukin","year":"2019","unstructured":"Dukin MJ, Feng Q, Suda KJ, Lockhart PB, Thornhill MH, Warren K, et al. Longitudinal antibiotic prescribing trends among US dental specialists within a pharmacy benefits manager, 2013 through 2015. J Am Dent Assoc. 2019;150:846\u201353.","journal-title":"J Am Dent Assoc"},{"key":"1367_CR28","doi-asserted-by":"publisher","first-page":"e730","DOI":"10.1111\/eje.12387","volume":"22","author":"E Jones","year":"2018","unstructured":"Jones E, Cope A. Knowledge and attitudes of recently qualified dentists working in Wales towards antimicrobial prescribing and resistance. Eur J Dent Educ. 2018;22:e730\u20136. https:\/\/doi.org\/10.1111\/eje.12387.","journal-title":"Eur J Dent Educ"},{"key":"1367_CR29","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/hpm.2971","volume":"35","author":"PP Pisarnturakit","year":"2020","unstructured":"Pisarnturakit PP, Sooampon S, Sooampon S. Managing knowledge for health care quality: an investigation of rational antibiotic use among Thai dentists. Int J Health Plan Manag. 2020;35:606\u201313.","journal-title":"Int J Health Plan Manag"},{"issue":"24","key":"1367_CR30","first-page":"320","volume":"2018","author":"Japanese association for infectious disease, Japanese society of chemotherapy; JAID, JSC committee for developing treatment guide and guidelines for clinical management of infectious disease; odontogenic infection working group","year":"2016","unstructured":"Japanese association for infectious disease, Japanese society of chemotherapy; JAID, JSC committee for developing treatment guide and guidelines for clinical management of infectious disease; odontogenic infection working group. The JAID\/JSC guidelines for clinical management of infectious disease-odontogenic infections. J Infect Chemother. 2016;2018(24):320\u20134.","journal-title":"J Infect Chemother"},{"key":"1367_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2165\/00003088-200948020-00002","volume":"48","author":"CB Landersdorfer","year":"2009","unstructured":"Landersdorfer CB, Bulitta JB, Kinzig M, Holzgrabe U, Sorgel F. Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations. Clin Pharmacokinet. 2009;48:89\u2013124.","journal-title":"Clin Pharmacokinet"},{"key":"1367_CR32","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/S0278-2391(10)80131-4","volume":"51","author":"JW Hudson","year":"1993","unstructured":"Hudson JW. Osteomyelitis of the jaws: a 50-year perspective. J Oral Maxillofac Surg. 1993;51:1294\u2013301.","journal-title":"J Oral Maxillofac Surg"},{"key":"1367_CR33","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.bone.2014.12.021","volume":"73","author":"T Ikeda","year":"2015","unstructured":"Ikeda T, Kuraguchi J, Kogashiwa Y, Yokoi H, Satomi T, Hohno N. Successful treatment of bisphosphonate-related osteonecrosis of the jaw (BRONJ) patients with sitafloxacin: new strategies for the treatment of BRONJ. Bone. 2015;73:217\u201322.","journal-title":"Bone"},{"key":"1367_CR34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.coms.2006.11.010","volume":"19","author":"M Mehrabi","year":"2007","unstructured":"Mehrabi M, Allen JM, Roser SM. Therapeutic agents in perioperative third molar surgical procedures. Oral Maxillofac Surg Clin N Am. 2007;19:69\u201384.","journal-title":"Oral Maxillofac Surg Clin N Am"},{"key":"1367_CR35","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/j.joms.2007.03.004","volume":"65","author":"YF Ren","year":"2007","unstructured":"Ren YF, Malmstrom HS. Effectiveness of antibiotic prophylaxis in third molar surgery: a meta-analysis of randomized controlled clinical trials. J Oral Maxillofac Surg. 2007;65:1909\u201321.","journal-title":"J Oral Maxillofac Surg"},{"key":"1367_CR36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0025-7125(16)31227-5","volume":"67","author":"A Alanis","year":"1983","unstructured":"Alanis A, Weinstein AJ. Adverse reactions associate with the use of oral penicillins and cephalosporins. Med Clin N Am. 1983;67:113\u201329.","journal-title":"Med Clin N Am"},{"key":"1367_CR37","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1177\/0022034519863645","volume":"98","author":"MH Thornhill","year":"2019","unstructured":"Thornhill MH, Dayer MJ, Durkin MJ, Lockhart PB, Baddour LM. Risk of adverse reactions to oral antibiotics prescribed by dentists. J Dent Res. 2019;98:1081\u20137.","journal-title":"J Dent Res"},{"key":"1367_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003811.pub2","author":"G Lodi","year":"2012","unstructured":"Lodi G, Figini L, Sardella A, Carrassi A, Del Fabbro M, Furness S. Antibiotics to prevent complications following tooth extractions. Cochrane Database Syst Rev. 2012. https:\/\/doi.org\/10.1002\/14651858.CD003811.pub2.","journal-title":"Cochrane Database Syst Rev"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-020-01367-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12903-020-01367-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-020-01367-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T19:10:29Z","timestamp":1610046629000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-020-01367-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1367"],"URL":"https:\/\/doi.org\/10.1186\/s12903-020-01367-1","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"6 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics committee of Kobe University Hospital (certificate No. B200079) and was conducted in accordance with the Declaration of Helsinki. There was no need of individual consent and need of informed consent was waived by the Ethics committee of Kobe University Hospital in this study because this was secondary data analysis and details of patients anonymized.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}